Healthcare - Press Releases

Innovative Veterinary Practice Improvement Company Drives Veterinary Practice Efficiency, GreaterPatient Care, and Customer Loyalty with Cutting-Edge AI Enhancements

CLEVELAND, Jan. 24, 2025 /PRNewswire/ -- Standard Wellness Holdings, LLC ("Standard Wellness"), a multi-state, vertically integrated cannabis operator focused on improving quality of life through safe and easy access to cannabis, announces partnership with Miss Grass, a female-founded, community-driven brand, to distribute its line of premium THC products to Missouri.

PLEASANT GROVE, Utah, Jan. 24, 2025 /PRNewswire/ --In response to the devastating wildfires sweeping across California, dTERRA Healing Hands has taken swift action to support those affected. To date, the organization has sent 6,950 relief kits to the affected areas, which will be distributed by 134 dedicated Wellness Advocates.

NEW YORK, Jan. 24, 2025 /PRNewswire/ -- Revolutionary skin tightening is at your fingertips thanks to the innovative technology behind Quantum RF Skin Tightening by InMode. And plastic surgeon and NewBeauty Top Doctor, Elie Levine, MD of Plastic Surgery and Dermatology of NYC is one of the very first to offer true expertise in this exciting new device.

Recognizing nine student entrepreneurs for their innovative solutions

WASHINGTON, Jan. 24, 2025 /PRNewswire/ --

ST. PETERSBURG, Fla., Jan. 24, 2025 /PRNewswire/ -- Johnson PopeBokor Ruppel & Burns, LLP is excited to announce that Adam D. Kravatz has joined the firm as an associate in its Healthcare Practice Group, further solidifying the firm's reputation as a leader in delivering exceptional legal services to clients in Florida and beyond.

PITTSBURGH, Jan. 24, 2025 /PRNewswire/ -- "Cold water therapy can offer a lot of health benefits, but standard methods can be expensive and waste water and ice," said one of two inventors, fromDubbo, NSW, Australia, "so we invented the ICE RAIN. Our design would provide a more affordable and efficient alternative to traditional plunge pools and other means of engaging in cold plunge therapy."

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare primary immunodeficiency, has been validated for review and is now under evaluation with the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). In April 2024, mavorixafor received U.S. Food and Drug Administration approval as XOLREMDI, an oral, once-daily treatment for use in patients 12 years of age and older with WHIM syndrome.

Springbok's AI-Powered Muscle Analytics Is Advancing Precision Medicine, Elite Sports Performance, and Longevity on a Global Scale

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare primary immunodeficiency, has been validated for review and is now under evaluation with the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). In April 2024, mavorixafor received U.S. Food and Drug Administration approval as XOLREMDI, an oral, once-daily treatment for use in patients 12 years of age and older with WHIM syndrome.

PITTSBURGH, Jan. 24, 2025 /PRNewswire/ -- "I'm a dentist and after years of treating people from all walks of life wanted to create an easy and effective way to treat tooth decay at a fraction of the cost of more conventional drill and fill methods," said an inventor, fromChambersburg, Pa., "so I invented THE SILVER SOLUTION. My design offers an alternative to brushing when on-the-go or away from home, could help improve a person's oral health, and from what I have seen in my practice using one of the active ingredients also control bacterial infections."

FRISCO, Texas, Jan. 24, 2025 /PRNewswire/ -- Silver Gene, a pioneer in nutritional genetic technology and personalized health solutions, is proud to announce its participation in the upcomingDxPx Conference Europe, taking place in Dsseldorf, Germany January 26-27th.

LOS ANGELES, Jan. 24, 2025 /PRNewswire/ -- ColdVentures, a leading medical device company focused on combating heat-related deaths, has announced a distribution agreement with Medco Sports Medicine Medco), the nation's premier provider of sports medicine supplies and equipment. This collaboration will bring ColdVentures' groundbreaking ColdVest technology to athletic trainers, educators and sports medicine professionals, providing a critical tool to prevent and treat heat stroke in athletes and students.

All profits on February 3 will be donated to the American Tinnitus Association to honor Texas Roadhouse Founder Kent Taylor and raise awareness of tinnitus, a poorly understood auditory disorder.

ROSEMONT, Ill., Jan. 24, 2025 /PRNewswire/ -- (AANA) - In honor of National CRNA Week (Jan. 19-25, 2025), U.S. House Representatives Jan Schakowsky (D-IL), Dave Joyce (R-OH), Suzanne Bonamici (D-OR), Brian Fitzpatrick (R-PA), Eleanor Holmes Norton (D-DC) and Paul Tonko (D-NY) again introduced a bipartisan House Resolution on the House floor,"Recognizing the roles and the contributions of America's Certified Registered Nurse Anesthetists (CRNAs) and their critical role in providing quality healthcare for the public and the nation's armed forces for more than 150 years and through multiple public health emergencies and beyond."

Antony Kaliyadan, MD, Brian Bethea, MD, and John Wang, MD, at MedStar Union Memorial Hospital in Baltimore, perform Maryland's first FDA-approved tricuspid valve replacements, Jan. 7th. MedStar Health (PRNewsfoto/MedStar Health)

PRINCETON, N.J., Jan. 24, 2025 /PRNewswire/ -- Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced that it will share real-world data about the crucial role of LONSURF (trifluridine/tipiracil) in a combination treatment for metastatic colorectal cancer (mCRC) during the American Society of Clinical Oncology 2025 Gastrointestinal Cancers Symposium, January 23-25 in San Francisco.

Scholarship and grant applications now available

Michael Tan appointed Chief Executive Officer, withPayton Nyquvest appointed Executive Chair.

Dry macular degeneration is a common eye disorder among people aged above 50 years. It causes blurred or reduced central vision due to thinning of the macula. The macula is the part of the retina responsible for clear vision in a direct line of sight. The pharmaceutical industry is increasingly focused on developing pathway-based therapies for dry AMD, with promising treatments like ALK-001 and LBS-008 in trials, though a combination approach may be needed to fully inhibit disease progression.

Los Angeles County Seal Logo (PRNewsfoto/Los Angeles County Department of Public Health) Los Angeles County Department of Public Health Logo (PRNewsfoto/Los Angeles County Department of Public Health) Fentanyl Frontline Logo (PRNewsfoto/Los Angeles County Department of Public Health) End Overdose Logo (PRNewsfoto/Los Angeles County Department of Public Health)

SAN DIEGO, Jan. 23, 2025 /PRNewswire/ --Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting Alluminox platform-based photoimmunotherapy, today announcedthe initiation of its global multi-regional Phase 3 clinical trial evaluating ASP-1929 photoimmunotherapy in combination with anti-PD-1 (pembrolizumab) as a first-line therapy for recurrent head and neck squamous cell carcinoma (HNSCC) (Protocol number: ASP-1929-381 / Acronym: ECLIPSE* / ClinicalTrials.gov Identifier: NCT06699212). The first patient in this trial recently received a study treatment at the Avera Cancer Institute in Sioux Falls, South Dakota, USA. Alongside the U.S., patient enrollment is slated for sites in Japan and Taiwan, followed by additional countries and regions.

LOS NGELES, 23 de enero de 2025 /PRNewswire-HISPANIC PR WIRE/ -- El Departamento de Salud Pblica del Condado de Los ngeles, a travs de su Oficina de Prevencin y Control del Abuso de Sustancias (SAPC),anunciuna nueva asociacin con End Overdose , unaorganizacin dedicada a prevenir las sobredosis de drogas a travs de la educacin, la capacitacin y el alcance comunitario, para abordar la crisis del fentanilo en el Condado de Los ngeles. Juntos, Salud Pblica y End Overdose tendrn presencia en varios festivales musicales y culturales en todo el condado de Los ngeles en 2025. Los asistentes tendrn la oportunidad de aprender sobre los riesgos del fentanilo, recibir capacitacin y certificacin sobre cmo administrar naloxona, recibir naloxona gratis y acceder a recursos gratuitos para ayudar a prevenir y revertir las sobredosis.

ORINDA, Calif., Jan. 23, 2025 /PRNewswire/ -- CG Pharmaceuticals (CG Pharma), a clinical biopharmaceutical company located in theSan Francisco Bay Area, was established as an independent entity in 2024 after licensing ivaltinostat from CG Invites. The company has since been conducting various research projects on ivaltinostat in the U.S. including the metastatic pancreatic cancer (mPDAC) clinical trial(NCT05249101). The results of the completed Phase 1b studyand the progress report of Phase 2 will be presentedat theASCO Gastrointestinal Symposium onFriday, January 24.